Authors: van Dijck, JAAM Festen, J de Kleijn, EMHA Kramer, GWPM Tjan-Heijnen, VCG Verbeek, ALM

Citation: Jaam. Van Dijck et al., Treatment and survival of patients with non-small cell lung cancer stage IIIA diagnosed in 1989-1994: a study in the region of the Comprehensive Cancer Centre East, The Netherlands, LUNG CANC, 34(1), 2001, pp. 19-27

Authors: Van Zandwijk, N Smit, EF Kramer, GWP Schramel, F Gans, S Festen, J Termeer, A Schlosser, NJJ Debruyne, C Curran, D Giaccone, G

Citation: N. Van Zandwijk et al., Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955), J CL ONCOL, 18(14), 2000, pp. 2658-2664

Authors: Hannen, EJM Bulten, J Festen, J Wienk, SM de Wilde, PCM

Citation: Ejm. Hannen et al., Polymorphous low grade adenocarcinoma with distant metastases and deletions on chromosome 6q23-qter and 11q23-qter: a case report, J CLIN PATH, 53(12), 2000, pp. 942-945

Authors: Tjan-Heijnen, VCG Biesma, B Festen, J Splinter, TAW Cox, A Wagener, DJT Postmus, PE

Citation: Vcg. Tjan-heijnen et al., Detrimental effects of prechemotherapy filgrastim - In reply, J CL ONCOL, 17(3), 1999, pp. 1089-1090